ArticleFrontiers in endocrinology2026
IVF outcomes in cancer survivors: lower ovarian response and early embryo development but comparable success in frozen embryo transfer cycles - a retrospective cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate whether women who have undergone cancer chemotherapy or radiotherapy achieve assisted reproductive technology (ART) outcomes comparable to those of non-cancer patients with equivalent ovarian reserve, and to explore the association between ART outcomes and the interval after chemotherapy or radiotherapy. Design: Retrospective cohort study. Patients: 32 cancer survivors who had received chemotherapy or radiotherapy and 160 matched control women had similar ovarian functions without malignancy. Main outcomes: Number of oocytes retrieved, embryo development, cumulative pregnancy rate and cumulative live birth rate. Result: This study performed inverse probability of treatment weighting (IPTW) to minimize potential confounding factors. After IPTW adjustment, the baseline characteristics were well balanced between the survivor and control groups. In the weighted regression analysis, the survivors exhibited a lower number of MII oocytes (β=-3.06 95%CI [-5.568, -0.555], Conclusion: This study demonstrated that when women with a history of chemotherapy or radiotherapy had similar ovarian function with women who had not experienced cancer still exhibited reduced number of MII oocyte and lower high-quality embryo rate and there was no difference in FET outcomes between survivor and control group. We also found no significant difference in different treat-to- IVF/ICSI interval in FET cycle outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.